Yarrow Bioscience YARW
NASDAQ YARW
$24.33 +0.14 (+0.60%)
As of: Sep 30, 2026 · 11:41 AM EDT

Yarrow Bioscience (YARW) Non-Current Debt (2019 - 2021)

Updated

Yarrow Bioscience (YARW) reported Non-Current Debt of $33.27 million for Q1 2021, up 1.4% from $32.82 million a year earlier and up 0.3% from the prior quarter.

Analysis

Yarrow Bioscience (YARW) Non-Current Debt (2019 - 2021) Analysis & Trends

At the end of FY2020, Yarrow Bioscience posted Non-Current Debt of $33.17 million, up 1.4% from FY2019.

  • By year, Non-Current Debt came in at $32.73 million in FY2019.
  • Per Business Quant data, the three quarters before Q1 2021 came in at $33.17 million (Q4 2020), $33.02 million (Q3 2020) and $32.92 million (Q2 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Yarrow Bioscience 20.59 Mn -95.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 33.27 Mn
Dec 31, 2020 33.17 Mn
Sep 30, 2020 33.02 Mn
Jun 30, 2020 32.92 Mn
Mar 31, 2020 32.82 Mn
Dec 31, 2019 32.73 Mn
API Access

Yarrow Bioscience Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=YARW&period=max&api_key=YOUR_API_KEY